Table 1.
Characteristics of clinical isolates.
| Characteristic | MSSA n = 98 n (%) |
MRSA n = 92 n (%) |
Total Isolates n = 190 n |
p-Value 1 |
|---|---|---|---|---|
| Sample source | 0.865 | |||
| Blood cultures | 34 (50.7) | 33 (49.3) | 67 | |
| Wounds | 64 (52) | 59 (48) | 123 | |
| Presence of pvl | 0.001 2 | |||
| Yes | 11 (28.2) | 28 (71.8) | 39 | |
| No | 87 (57.6) | 64 (42.4) | 151 | |
| Susceptibility to mupirocin | <0.001 | |||
| Resistant | 2 (11.1) | 16 (88.9) | 18 | |
| Sensitive | 96 (59.25) | 76 (40.75) | 162 | |
| Mupirocin’s MIC (mg/L) | 0.023 | |||
| Mean | 15.3 | 178.75 | 94.45 | |
| Median (Q1, Q3) | 0.125 (0.94, 0.19) | 0.19 (0.102, 0.865) | 0.125 (0.094, 0.25) |
1 Chi-squared test, Mann–Whitney test. 2 Bold values indicate statistical significance.